Investors in Life Science

Aravis is an independent Swiss on-shore private equity fund manager. With our entrepreneurial experience, we take leading positions in our invested portfolio companies and understand the balance between finance, commercial assets and people. We have expanded our team expertise from biotech, renewable energy and luxury goods to creative and digital space as well as industrial high-tech. Our fifth fund focuses on Swiss growth companies that are commercially established (more than CHF 5m turnover) and in need of capital to expand their product offering and enter new markets.

Beyond Impact VC www.beyondimpact.vc advises in the creation of portfolios that accelerate our transition to a cruelty-free world, with a focus on : Organic crop production and distribution Plant-based meat, fish and leather alternatives Vegan convenience foods «Clean» meat, fish and leather Vegan catering and restaurants Vegan clothing and accessories Vegan lifestyle businesses. Replacements for animal testing Cruelty-free, organic household products, toiletries and cosmetics

Headquartered in Paris and London, Óskare Capital specializes in venture-stage investments in the Deeptech and Life Sciences sectors.

The company was successful Lead- and Co-investor in a number of Grow-Ups in the Life Science Technologies, Pharmaceuticals Industries Solutions, Renewable Energies and Process Equipment and Management. By End of June 2020, Abalis Finance AG has completed the structured exit process and subsequently ended it’s active role in respective participations As a consequence, Abalis Finance AG was downsized and Andres Huber and Andreas Miescher have left the Board.

Experior Venture Fund is the leading early and growth stage venture capital investor in Poland. EVF invests between EUR 200k and EUR 3m in high-growth innovative companies that are driving transformative change in their industries. The firm has a dedicated team of professionals who support entrepreneurs in delivering success. Support of Experior Venture Fund is tailored towards the specific needs of each portfolio company, the fund provides a combination of both capital/financing and operational know-how driving value creation of portfolio companies.

Black Pearls VC is a venture capital firm investing in leading tech startups with a focus on Life Quality Technologies, supporting ambitious entrepreneurs to build global companies in areas like Digital Health and Enterprise Software.

Rhone-Alpes Création is a venture capital firm specializing in early-stage investments in software and biotechnology sectors. Committed to fostering innovation and growth, they provide crucial funding and support to startups during their formative stages. With a focus on high-potential companies, Rhone-Alpes Création aims to drive advancements in technology and life sciences, contributing to the development of groundbreaking solutions and the overall success of emerging ventures.

Limousin Participations is a specialized French venture capital firm focusing on seed and startup investments. They provide crucial early-stage funding to innovative companies, supporting their growth and development across various sectors.

Cathay Health, part of Cathay Capital, is a global fund focusing on healthcare, life sciences, and technology intersections. Operating from key hubs like San Francisco, New York, London, and Shanghai, we invest in venture to growth-stage companies across Europe, North America, and Asia. Our aim is to catalyze transformative advances in medicine through tech-enabled solutions, fostering collaboration across borders and industries to unlock new markets and enhance patient care globally.

Montis seeks to work with great teams, scalable business models, innovative and already market validated products on providing for expansion and growth capital within the following two sectors: Industry 4.0 We aim to be at the heart of a Fourth Industrial Revolution by investing into a confluence of robotics, artificial intelligence, internet of things, big data or deep tech. Life Science We look for projects in fields of biotechnology, pharmaceuticals, biomedical technologies, life systems technologies, nutraceuticals, cosmeceuticals, food processing, environmental and biomedical devices.

We support #HealthTech and #CleanTech innovators at every stage of building and developing valuable companies using innovative technologies with global potential. We invest 0.2-1 M Euro. We support entrepreneurs and technologies that matter.

3XP Global is an Asset Management firm that aggregates a unique track record in terms of ESG Integration in the Investment Process and Active Role by supporting founders during the all life of the investments cycle. Sustainability Best Practices for Sustainable Investments are our Ethos! Being the first financial company as a B Corp in Portugal, 3xP Global has the 17 United Nations SDG’s (Sustainable Development Goals) as key core values, sustained by the idea that along with sustainability comes return. We are UN PRI signatories and follow the GRI Standards Reporting. 3XP Global invests in companies whose sustainable trends and practices create real value for investors while contributing to a more Sustainable EARTH. Regulated and supervised by Portuguese Securities Market Commission (CMVM), 3XP Global ensures full Transparency, Integrity and Independence. We are fully committed to lead all investments to increase companies' sustainability levels into business models. Therefore, 3XP Global provides the leading platform Grow Sustainable connecting founders to international markets, from Europe to Asia and America.